These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 10672974

  • 21. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M.
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [Abstract] [Full Text] [Related]

  • 22. Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice.
    Renoir T, Païzanis E, El Yacoubi M, Saurini F, Hanoun N, Melfort M, Lesch KP, Hamon M, Lanfumey L.
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1149-62. PubMed ID: 18611291
    [Abstract] [Full Text] [Related]

  • 23. Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain.
    Moreau X, Jeanningros R, Mazzola-Pomietto P.
    Neuropsychopharmacology; 2001 Jun; 24(6):652-62. PubMed ID: 11331145
    [Abstract] [Full Text] [Related]

  • 24. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells.
    Jones DC, Lau SS, Monks TJ.
    J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
    Watanabe Y, Sakai RR, McEwen BS, Mendelson S.
    Brain Res; 1993 Jun 25; 615(1):87-94. PubMed ID: 8364729
    [Abstract] [Full Text] [Related]

  • 27. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI, Williams JL, Green AR.
    Br J Pharmacol; 1995 Aug 25; 115(7):1281-9. PubMed ID: 7582557
    [Abstract] [Full Text] [Related]

  • 28. The role of dopaminergic systems in the perinatal sensitivity to 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in rats.
    Aguirre N, Barrionuevo M, Lasheras B, Del Río J.
    J Pharmacol Exp Ther; 1998 Sep 25; 286(3):1159-65. PubMed ID: 9732373
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
    Martínez-Esparza J, Oficialdegui AM, Pérez-Silanes S, Heras B, Orús L, Palop JA, Lasheras B, Roca J, Mourelle M, Bosch A, Del Castillo JC, Tordera R, Del Río J, Monge A.
    J Med Chem; 2001 Feb 01; 44(3):418-28. PubMed ID: 11462981
    [Abstract] [Full Text] [Related]

  • 32. MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: effects on serotonin transporter densities.
    Boot BP, Mechan AO, McCann UD, Ricaurte GA.
    Eur J Pharmacol; 2002 Oct 25; 453(2-3):239-44. PubMed ID: 12398910
    [Abstract] [Full Text] [Related]

  • 33. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
    Callaghan PD, Owens WA, Javors MA, Sanchez TA, Jones DJ, Irvine RJ, Daws LC.
    J Neurochem; 2007 Feb 25; 100(3):617-27. PubMed ID: 17181558
    [Abstract] [Full Text] [Related]

  • 34. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM, Monge A, Del Río J, Lasheras B.
    Eur J Pharmacol; 2002 May 03; 442(1-2):63-71. PubMed ID: 12020683
    [Abstract] [Full Text] [Related]

  • 35. 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity.
    Williams MT, Schaefer TL, Ehrman LA, Able JA, Gudelsky GA, Sah R, Vorhees CV.
    Brain Res; 2005 Mar 28; 1039(1-2):97-107. PubMed ID: 15781051
    [Abstract] [Full Text] [Related]

  • 36. Dissociation of the plasticity of 5-HT1A sites and 5-HT transporter sites.
    Pranzatelli MR.
    Neurochem Res; 1994 Mar 28; 19(3):311-5. PubMed ID: 8177370
    [Abstract] [Full Text] [Related]

  • 37. Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum.
    Kanthasamy A, Sprague JE, Shotwell JR, Nichols DE.
    Neuroscience; 2002 Mar 28; 114(4):917-24. PubMed ID: 12379247
    [Abstract] [Full Text] [Related]

  • 38. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
    Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR.
    Br J Pharmacol; 2002 Jan 28; 135(1):170-80. PubMed ID: 11786492
    [Abstract] [Full Text] [Related]

  • 39. Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
    Mlinar B, Corradetti R.
    Eur J Neurosci; 2003 Sep 28; 18(6):1559-71. PubMed ID: 14511335
    [Abstract] [Full Text] [Related]

  • 40. Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.
    McGregor IS, Clemens KJ, Van der Plasse G, Li KM, Hunt GE, Chen F, Lawrence AJ.
    Neuropsychopharmacology; 2003 Aug 28; 28(8):1472-84. PubMed ID: 12700695
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.